News & Publications

03-19-2013	EGEN, Inc. Announces a Phase I Clinical Trial for Advanced Ovarian Cancer
09-26-2011	EGEN, Inc. Collaborates With Nanotechnology Characterization Laboratory on Brain Cancer Therapy
02-02-2011	FDA Awards EGEN, Inc. Orphan -Drug Grant for Clinical Development of EGEN-001 for Treatment of Ovarian Cancer
12-13-2010	EGEN, Inc. Announces that Phase II Clinical Trial for Advanced Ovarian Cancer is Open for Enrollment
	News Archive